Choosing the Best Injection Site for Your Weight Loss Pen

Mounjaro and Wegovy can both be injected into the abdomen, front thigh, or outer upper arm — rotating the site each week helps protect the skin.
All three sites absorb the medicine effectively; the abdomen is the most commonly chosen because it is easy to reach and pinch a fold of skin.
Injecting into active, exercised or sunburned skin, or areas affected by lipodystrophy, is best avoided, your prescriber and Patient Information Leaflet will explain why.
Correct needle change for every injection and wiping the skin beforehand are standard practice; links to compatible accessories are below if needed.

For Mounjaro and Wegovy, the three licensed injection sites are the abdomen, the front of the thigh, and the outer upper arm — and rotating between them every week is more important than picking one perfect spot. Most people have a strong preference for the abdomen, but the clinical evidence shows all three sites deliver the medicine reliably. These are prescription-only medicines: a GPhC-registered prescriber assesses your suitability before treatment begins, and your Patient Information Leaflet gives the exact technique guidance for your specific pen.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Site by site: what the guidance actually says about where to inject

The myth that one site is clinically superior, and why it persists

A question our prescribers hear regularly is whether the abdomen somehow delivers the medicine faster or more completely than the thigh. It is an understandable assumption: GLP-1 medicines work in ways that feel almost magical at first, and people naturally want to optimise every detail. The short answer is that the published evidence does not rank the three approved sites by effectiveness. The NHS guidance for both tirzepatide and semaglutide lists the abdomen, front of the thigh, and outer upper arm as equivalent options. What does vary is how easy a site is to reach, and whether blood flow at the moment of injection differs, hence why injecting into a muscle you have just exercised hard is worth avoiding.

The myth probably persists because earlier insulin research showed meaningful absorption differences by site. GLP-1 receptor agonists behave differently: they are absorbed through subcutaneous fat, and since all three sites have adequate fatty tissue in most adults, the differences are small in practice. Rotation matters far more than site selection.

If you are curious about how the sites compare in more detail, the GLP-1 injection site guide on this site goes deeper into the pharmacokinetic picture.

How to choose a site that works for your routine

Practicality shapes adherence. The abdomen is the first choice for many people simply because it is visible, easy to pinch, and accessible whether sitting at a desk or on the sofa. Aim at least five centimetres from the navel and avoid the belt line. The front thigh is a strong second option, especially useful if your abdomen is affected by scar tissue or lipodystrophy from previous injections. Sit down, let the leg relax, and use the middle third of the thigh. The outer upper arm is convenient once you are comfortable with the technique, though self-injection there is slightly trickier; many people keep it as a third rotation option rather than a default.

One concrete routine detail worth mentioning: keeping your pen in the fridge door rather than at the back of the shelf means it is easier to spot, easier to grab on the same day each week, and less likely to be damaged by accidentally freezing at the back of the fridge. Room-temperature windows before injecting exist, but the exact timing differs between Mounjaro and Wegovy, always follow your Patient Information Leaflet rather than guessing.

For a fuller breakdown of rotation patterns and technique by site, the site comparison guide covers the practical steps in detail.

Keeping the injection site healthy over months of treatment

Weight loss treatment with Mounjaro or Wegovy typically continues for many months. That is a lot of injections, and skin health at the site matters. Lipodystrophy (lumps or indentations caused by repeated injections in one small area) can slow absorption and cause unpredictable results over time. Rotating across all three approved sites, and varying the precise spot within each site, reduces the risk significantly.

Clean technique also helps. Wiping the skin before injecting is standard practice; sterile alcohol swabs are a low-cost item worth keeping in the same drawer as your pen. Changing the needle for every injection reduces both injection-site discomfort and the risk of skin trauma, blunt needles require more force, which increases bruising. Used needles should go into a sharps container rather than the household bin. The injection site overview covers disposal alongside technique if you want everything in one place.

The NHS tirzepatide guidance also notes that you should avoid injecting into skin that is red, broken, bruised or affected by a rash, common sense, but easy to overlook when you are in a hurry. The NHS medicines page for tirzepatide covers this alongside storage and other practical guidance.

When technique questions are best answered by a prescriber

This page covers the general guidance that applies across both licensed weight-loss injections. Individual situations (a history of skin conditions, previous bariatric surgery, limited mobility, or simply anxiety about injecting for the first time) are worth discussing with a prescriber directly. At nume, every patient has access to aftercare support seven days a week, so questions that come up mid-treatment do not have to wait.

If you are weighing up which medicine and which route might suit you overall, the guide to choosing between weight loss injections is a reasonable next step. And if you are still at the stage of understanding what these treatments involve more broadly, the weight loss injections overview covers the licensed options, how they work, and what the evidence shows.

Cost context is a fair question too. The weight loss injection cost guide explains what private treatment typically includes and why headline prices can be misleading. When you are ready to speak to a prescriber, starting a free consultation is the straightforward next step, same-day clinical review by a GPhC-registered prescriber, no waiting list. The NHS medicines page for semaglutide is also worth bookmarking alongside your Patient Information Leaflet.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions